Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED)

This study has been completed.
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp. Identifier:
First received: June 1, 2007
Last updated: April 27, 2015
Last verified: April 2015